Synaptic transmission in neurons is a measure of communication at synapses, the points of contact between axons and dendrites. The magnitude of synaptic transmission is a reflection of the strength of these synaptic connections, which in turn can be altered by the frequency with which the synapses are stimulated, the arrival of stimuli from other neurons in the appropriate temporal window, and by neurotrophic factors and neuromodulators. The ability of synapses to undergo lasting biochemical and morphological changes in response to these types of stimuli and neuromodulators is known as synaptic plasticity, which likely forms the cellular basis for learning and memory, although the relationship between any one form synaptic plasticity and a particular type of memory is unclear. RNA metabolism, particularly translational control at or near the synapse, is one process that controls long-lasting synaptic plasticity and, by extension, several types of memory formation and consolidation. Here, we review recent studies that reflect the importance and challenges of investigating the role of mRNA translation in synaptic plasticity and memory formation.
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Changes in gene expression are required to convert shortterm memory (STM), lasting less than ;1 h, to long-term memory (LTM) in both invertebrates and vertebrates (Kandel 2001) . At the cellular level, long-lasting changes in synaptic strength, typically called synaptic plasticity, refers to the ability of neurons to alter communication with each other via synaptic connections in response to specific patterns of electrical stimulation and/or neurotrophic factors, and is generally considered to underlie LTM (Malenka and Nicoll 1999) . The most studied forms of long-lasting synaptic plasticity in mammals, particularly rodents, are long-term potentiation (LTP) and longterm depression (LTD), which refer to long-lasting increases or decreases, respectively, in synaptic strength (Malenka and Bear 2004) . Most of the work on LTP and LTD has been conducted in the hippocampus, a structure re-quired for memory consolidation. Similar to memory, LTP can be defined temporally with respect to the requirement for new gene expression: Early-phase LTP (E-LTP), like STM, does not require new gene expression, whereas latephase LTP (L-LTP) does. Throughout the 1990s, molecular studies of the regulation of gene expression in the context of LTM formation and L-LTP focused almost exclusively on transcription, especially the transcription factor CREB (Silva et al. 1998) . However, in the last five years, there have been several studies delineating the mechanisms of translational control underlying both LTM and L-LTP.
Pharmacological inhibitors of transcription and translation block L-LTP induced by electrical stimulation (Klann and Dever 2004; . Ribosomes, translation factors, and mRNA are present not only in the neuronal soma, but also in dendrites and dendritic spines (Steward and Schuman 2001) , suggesting that local (synaptodendritic) protein synthesis could trigger long-lasting synaptic plasticity without engaging transcription in the neuronal soma. Indeed, brain-derived neurotrophic factor (BDNF)-induced LTP, metabotropic glutamate receptordependent LTD (mGluR-LTD) and LTP induced by delivery of E-LTP-inducing stimulation in the presence of an agonist of b-adrenergic receptors (bAR-LTP) are all longlasting forms of plasticity that are blocked by protein synthesis inhibitors even when the neurons are physically severed from their cell bodies (Kang and Schuman 1996; Huber et al. 2000; Gelinas and Nguyen 2005) . Moreover, the inhibition of translation initiation results in the abrogation of L-LTP earlier than when transcription is inhibited (Kelleher et al. 2004; Banko et al. 2005 ) and L-LTP can be impaired with the direct application of a protein synthesis inhibitor to dendrites (Bradshaw et al. 2003) . Thus, local protein synthesis is a critical component of several forms of long-lasting hippocampal synaptic plasticity.
Mammalian target of rapamycin (mTOR), eIF4E-binding protein (4E-BP), and p70 S6 kinase (S6K) are involved in long-lasting hippocampal synaptic plasticity and memory mTOR is a protein kinase whose activation serves as one of the primary triggers for the initiation of cap-dependent translation via phosphorylation of 4E-BPs and S6Ks (Richter and Sonenberg 2005) . mTOR interacts the adaptor protein Raptor, which binds both 4E-BP and S6K (Choi et al. 2003; Schalm et al. 2003) ; mTOR/Raptor is referred to as mTOR complex 1 (mTORC1). Rapamycin, a drug that binds the protein FKBP12 and prevents mTOR from binding Raptor, disrupts mTORC1 and inhibits mTORcatalyzed 4E-BP and S6K phosphorylation (Kim et al. 2002) . The binding and inhibition of eIF4E by 4E-BP is regulated by mTOR-dependent phosphorylation (Gingras et al. 2001) . Unphosphorylated 4E-BP binds tightly to eIF4E, whereas 4E-BP phosphorylated by mTOR does not, thereby permitting eIF4F to form and initiation to proceed (Gingras et al. 2001) . mTOR also impacts translation by phosphorylating S6K, which then phosphorylates downstream targets such as ribosomal protein S6 and eIF4B (Raught et al. 2004) . Figure 1A describes some of the signaling events noted above.
In most systems, the phosphatidylinositol-3 kinase (PI3K) signaling pathway is upstream of mTOR. PI3K phosphorylates the membrane phospholipid phosphatidylinositol-4,5-bisphosphate (PIP2) converting it to PIP3, which then recruits Akt to the membrane where it is phosphorylated and activated by PDK1 (Brazil and Hemmings 2001) , as well as mTORC2, a complex of mTOR bound to a second adaptor protein, Rictor (Sabatini 2006) . Akt activates mTOR by inhibiting the tuberous sclerosis complex (TSC), a heterodimer of TSC1 (hamartin) and TSC2 (tuberin). TSC2 contains a GAP (GTPase-activating protein) domain for the small G-protein Rheb, and also is a substrate for Akt. When TSC2 is phosphorylated, its GAP activity decreases, resulting in Rheb and subsequent mTOR activation (Garami et al. 2003; Inoki et al. 2005) . A diagram depicting this signaling cascade is shown in Figure 1B . GTP-Rheb activates mTOR by antagonizing FKBP38, which binds mTOR and serves as an endogenous inhibitor of mTORC1 (Bai et al. 2007) . FKBP38 is structurally similar to FKBP12, however, the expression of FKBP38 is minimal in the adult rodent brain, whereas FKBP12 is very abundant (Hoeffer et al. 2008) . Although there is no direct evidence yet that FKBP12 binds either mTOR or Rheb, genetic deletion of FKBP12 increases the level of mTORC1 (Hoeffer et al. 2008 ), suggesting that FKBP12, like FKBP38, is an inhibitor of mTORC1 (Fig. 2) .
Protein synthesis-dependent LTP and mGluR-LTD trigger activation of signaling pathways that enhance translation factor phosphorylation in hippocampal slices. LTPinducing stimulation also triggers activation of mTOR, resulting in enhanced phosphorylation of 4E-BP2, the predominant 4E-BP isoform in the mouse brain, and enhanced eIF4F complex formation (Kelleher et al. 2004; Banko et al. 2005) . Moreover, LTP associated with increased S6K phosphorylation requires both mTOR-and extracellular signal-regulated kinase (ERK) (Tsokas et al. 2005 (Tsokas et al. , 2007 Hoeffer et al. 2008) , and is correlated with increased phosphorylation of ribosomal protein S6, a substrate of S6K (Kelleher et al. 2004; Tsokas et al. 2007; Antion et al. 2008b) . Importantly, many of the LTPinduced changes in translation factor phosphorylation occur in dendrites (Tsokas et al. 2005) . Similar increases Figure 1 . Signaling required for translational control during long-lasting synaptic plasticity and memory. (A) Signaling that couples group I mGluRs to translation initiation during mGluR-LTD. Activation of mGluR1 and mGluR5 triggers the activation of a PI3K/Akt/ mTOR/4E-BP signaling cascade that is required for the formation of eIF4F and the expression of mGluR-LTD (Banko et al. 2006) . mGluR-LTD also triggers the activation of a MEK/ERK/Mnk1 signaling cascades that are parallel to the mTOR cascade, with the signaling pathways converging on eIF4E (Gallagher et al. 2004; Banko et al. 2006) . (B) In most systems, phosphorylation of 4E-BP and S6K1 by mTORC1 requires Akt-dependent phosphorylation of TSC2, which inhibits its GAP activity and permits the activation of Rheb and mTOR that is bound to Raptor (mTORC1). mTORC1 is sensitive to inhibition by rapamycin bound to FKBP12. mTOR also can be bound to Rictor (mTORC2), which phosphorylates and activates Akt. Although there is substantial evidence consistent for a role of mTORC1 in long-lasting plasticity and memory, very little is known about the role of mTORC2 in these processes.
in mTOR phosphorylation and its downstream effectors occur with mGluR-LTD Banko et al. 2006; Antion et al. 2008a; Ronesi and Huber 2008) and bAR-LTP (Gelinas et al. 2007) . A diagram depicting signaling events known to couple group I mGluRs to mTOR and its substrate 4E-BP is shown in Figure 1A . Both pharmacological and genetic manipulations of translation factors in mice have demonstrated that proper translational control via mTOR is required for normal expression of LTP (Banko et al. 2005; Tsokas et al. 2005; Antion et al. 2008b; Hoeffer et al. 2008) , mGluR-LTD Banko et al. 2006; Antion et al. 2008a; Ronesi and Huber, 2008) , and bAR-LTP (Gelinas et al. 2007 ). Thus, dendritic up-regulation of translation initiation via mTORC1 is a critical component of longlasting, translation-dependent synaptic plasticity.
Several pharmacological studies have shown that rapamycin inhibition of mTORC1 signaling also blocks LTM formation in mammals (Tischmeyer et al. 2003; Parsons et al. 2006; Blundell et al. 2008; Schicknick et al. 2008 ). In addition, the training for several memory tasks coincides with increase in the phosphorylation of the downstream mTORC1 effectors 4E-BP and S6K in the hippocampus and amygdala, a brain structure involved in fear memory (Kelleher et al. 2004; Parsons et al. 2006; Hoeffer et al. 2008) . Finally, behavioral studies with mice carrying mutations in 4E-BP2, S6K1, and S6K2, indicate that mTOR signaling is required for normal LTM. 4E-BP2 knockout mice display impaired hippocampus-dependent and -independent forms of memory (Banko et al. 2005 . Although S6K1-and S6K2-deficient mice express L-LTP, S6K1-deficient exhibit impaired E-LTP and are deficient in multiple forms of learning and memory (Antion et al. 2008b ). S6K2-deficient mice also display several memory phenotypes (Antion et al. 2008b ). Thus, mice with genetic deletions of translational control molecules downstream from mTORC1 display a number of learning and memory impairments.
Genetic deletion of upstream molecules that result in up-regulation of mTORC1 signaling also have an impact on memory. Mice with a conditional, postnatal deletion of FKBP12, which results in increased levels of mTORC1 and increased phosphorylation of S6K1, display enhanced contextual fear memory as well as several examples of perservation and repetitive behaviors that are consistent with autistic and obsessive-compulsive behavior (Hoeffer et al. 2008 ). In addition, training for contextual fear memory triggers increased levels of mTORC1 and increased phosphorylation of S6K1 in wild-type mice (Fig.  2) . Both TSC1 and TSC2 heterozygous knockout mice exhibit impaired hippocampus-dependent memory (Goorden et al. 2007; Ehninger et al. 2008 ) and the memory impairments displayed by the TSC2 mutant mice are rescued by rapamycin treatment (Ehninger et al. 2008) . These results are intriguing as mutations in either TSC1 or TSC2 cause TSC, which often results in mental retardation and autism (DiMario 2004; Wiznitzer 2004) . Taken together these findings indicate that proper mTOR regulation is required for normal LTM.
GCN2 and eIF2a control long-lasting hippocampal synaptic plasticity and memory
Another translation factor involved in long-lasting synaptic plasticity and LTM is the eukaryotic initiation factor eIF2, which consists of a, b, and g subunits. eIF2 binds initiator Met-tRNA i Met and GTP to form a ternary complex, which then interacts with the small ribosomal subunit in its GTP-bound form. eIF2 is released from the ribosome in its GDP-bound state upon GTP hydrolysis. eIF2B catalyzes the exchange of GDP for GTP, which is required to reconstitute a functional ternary complex for a new round of initiation (Hinnebusch 2000) . Phosphorylation of eIF2a S51 blocks the GDP/GTP exchange, thereby slowing the dissociation of eIF2 from eIF2B and causing a decrease in general initiation. It is important to realize that although eIF2a phosphorylation causes a general inhibition of translation, it also up-regulates the expression of some mRNAs with upstream ORFs (uORFs) (Sonenberg and Dever 2003) , one of which encodes the transcriptional modulator ATF4 (Harding et al. 2000 ; see below). Proposed mechanism for mTORC1 activation following stimulation that induces L-LTP and training that triggers LTM. FKBP12 serves as an intracellular scaffold for either an mTOR inhibitory factor(s) or directly competes with Raptor for the mTOR FRB site. In either scenario, FKBP12 represses mTOR activity by blocking mTORC1 (mTOR-Raptor interactions). Stimulation that induces translation initiation (either electrical stimulation that induces L-LTP or training that induces LTM), signals either (1) the displacement of the inhibitory factor(s) interacting with FKBP12, or (2) the sequestration of FKBP12 from mTOR, thereby permitting Raptor access to the FRB. Translation-inducing signaling promotes mTOR access to 4E-BP2 and S6K, possibly through activation of additional mTORC1associated scaffolds (i.e., PRAS40), allowing translational initiation. Ras-homolog enriched in the brain (Rheb), proline-rich Akt/PKB substrate-40 kd (PRAS-40), FKBP12-binding domain (FRB), KIN (mTOR kinase catalytic domain), NRD (domain, site of serine 2448 phosphorylation).
Evidence that regulation of eIF2a phosphorylation plays an important role in long-lasting synaptic plasticity and LTM was provided by studies with GCN2 mutant mice (GCN2 is one of four kinases that can phosphorylate eIF2a), which have a decreased threshold for the induction of L-LTP (Costa-Mattioli et al. 2005) . This LTP phenotype also has been observed in mice with a genetic reduction of other translational repressors such as 4E-BP2 (Banko et al. 2005 ) and TSC2 (Ehninger et al. 2008) . Heterozygous eIF2a knock-in mice that harbor S51A also have a decreased threshold for the induction of L-LTP (Costa-Mattioli et al. 2007 ). Moreover, L-LTP is associated with decreased eIF2a phosphorylation, and prevention of this dephosphorylation with Sal003, an inhibitor of eIF2a phosphatases, results in the blockade of L-LTP (Costa-Mattioli et al. 2007 ). ATF4, which represses synaptic plasticity and memory formation (Abel et al. 1998; Chen et al. 2003) , is required for this impairment as L-LTP in hippocampal slices from ATF4 knockout mice cannot be blocked by Sal0003 (Costa-Mattioli et al. 2007) . Taken together, these findings indicate that the phosphorylation of eIF2a is required for the expression of L-LTP.
The phosphorylation of eIF2a also plays an important role in LTM. Animal training regimens that induce LTM is associated with decreased phosphorylation of eIF2a in the hippocampus and conversely, preventing traininginduced dephosphorylation of eIF2a with Sal003 prevents LTM formation (Costa-Mattioli et al. 2007 ). Behavioral studies with both GCN2 mutant mice and heterozygous eIF2a S51A knock-in mice indicate that reduction of eIF2a phosphorylation lowers the threshold for LTM formation (Costa-Mattioli et al. 2005 , 2007 . Interestingly, with more arduous training regimens, the GCN2 mutant mice have impaired LTM (Costa-Mattioli et al. 2007 ), which also has been observed in 4E-BP2 (Banko et al. 2005 ) and TSC2 (Ehninger et al. 2008 ) mutant mice. Thus, although reduction of eIF2a phosphorylation, which would enhance general translation, reduces the threshold for LTM, deletion of GCN2 and other mutations that derepress translation initiation can be deleterious to LTM formation.
FMRP and long-lasting hippocampal synaptic plasticity
As mentioned earlier, mGluR-LTD is a dendritic protein synthesis-dependent form of synaptic plasticity that can be induced by the selective group I mGluR agonist (RS)-3,5-dihydroxyphenylglycine (DHPG) (Huber et al. 2000; Hou and Klann 2004) . The product of the Fragile X gene, FMRP, almost certainly regulates translation during mGluR-LTD. For example, it has been reported that mGluR-LTD is augmented in Fmr1 knockout mice (Huber et al. 2002; Hou et al. 2006 ). In addition, several studies indicate that FMRP is translated in response to stimulation of group I mGluRs in synaptosomes (an in vitro preparation of synapses), cultured cortical and hippocampal neurons, hippocampal slices, and in the brain in vivo (Todd et al. 2003; Antar et al. 2004; Hou et al. 2006 ). Based on these results, Bear et al. (2004) suggested the ''mGluR theory of Fragile X mental retardation,'' which posited that excessive mGluR-dependent protein synthesis leads to multiple phenotypes in Fragile X syndrome (FXS). Subsequent studies showed that DHPG-induced mGluR-LTD induced in hippocampal slices resulted in the rapid translation of FMRP, which was dependent on the group I mGluR subtype mGluR5. Surprisingly, the rapid increase in FMRP levels associated with mGluR-LTD was followed by the ubiquitination and rapid destruction of FMRP; conversely, inhibition of the ubiquitin-proteasome pathway abrogated mGluR-LTD, as did the overexpression of FMRP ). mGluR-LTD in wild-type mice is associated with rapid increases in proteins whose mRNAs are bound by FMRP; such increases are abolished in Fmr1 knockout mice. In contrast to mGluR-LTD in wild-type mice, both protein synthesis ) and proteasome inhibitors ) have no effect on mGluR-LTD in Fmr1 knockout mice. These findings suggest that there is excessive translation of normally FMRP-bound mRNAs in Fmr1 knockout mice and that these mRNAs are translated during mGluR-LTD in wild-type mice. Moreover, these results also indicate that rather than an additional level of excessive translation, mGluR-dependent translational control is absent in Fmr1 knockout mice.
How would excessive mGluR-dependent translation occur in Fmr1 knockout mice? One possibility is that excessive activation of mGluRs occurs in the Fmr1 knockout mice, which triggers exaggerated activation of translational control pathways. In an elegant series of studies, Dö len et al. (2007) demonstrated that Fmr1 knockout mice with a 50% reduction in mGluR5 levels do not exhibit several FXS phenotypes. In addition, treatment of Fmr1 knockout mice with the mGluR5 antagonist MPEP also reverses FXS phenotypes (Yan et al. 2005 ); a similar rescue of phenotypes with mGluR antagonists has been observed in a Drosophila model of FXS (McBride et al. 2005) . Moreover, deletion of FMRP in Drosophila results in memory impairments that can be rescued by protein synthesis inhibitors, consistent with the notion that excessive translation impacts cognition in FXS (Bolduc et al. 2008) . Although an extensive characterization of translational control pathways has yet to be accomplished, phosphorylation of PDK-1, mTOR, and S6K1 can no longer be stimulated by DHPG in Fmr1 knockout mice ). Similar results have been observed for extracellular signal-regulated kinase ), which also is required for translational control in long-lasting hippocampal synaptic plasticity and memory (Gallagher et al. 2004; Kelleher et al. 2004; Banko et al. 2006 ). Thus, excessive basal translation and a lack of mGluR-dependent translational control are features that likely contribute to plasticity and behavioral phenotypes displayed by Fmr1 knockout mice.
FMRP binds many mRNAs, and increased expression of several of the encoded proteins has been observed in either the brains or neurons from Fmr1 knockout mice, including Arc/Arg3.1, aCaMKII, PSD-95, SAPAP3, and MAP1B (Zalfa et al. 2003; Todd et al. 2003; Hou et al. 2006; Muddashetty et al. 2007; Narayanan et al. 2008) .
Consistent with studies under conditions where FMRP is reduced (Park et al. 2008 ), mGluR-LTD in hippocampal slices is associated with protein synthesis-dependent increases in the levels of FMRP, MAP1B, aCaMKII, and Arc/Arg3.1 Waung et al. 2008) . The functional consequences of increased aCaMKII in mGluR-LTD are not clear, whereas MAP1B and Arc/ Arg3.1 synthesis is required for mGluR-dependent endocytosis of AMPA receptors (Davidkova and Carroll 2007; Waung et al. 2008; Park et al. 2008) . Dynamic translation of Arc/Arg3.1 also is required for the expression of mGluR-LTD (Waung et al. 2008) . Taken together, these studies indicate that translation of FMRP-bound mRNAs contributes to mGluR-LTD and suggest that excessive basal translation of these mRNAs might contribute to the plasticity and behavioral phenotypes observed in FXS.
Translational control by FMRP
The molecular mechanism by which FMRP modulates translation has been intensively studied but remains controversial. There is a general consensus that FMRP inhibits translation, although there is evidence consistent with it being a translational activator. For example, several investigators find that a substantial amount of FMRP sediments with polysomes (Stefani et al. 2004; Darnell et al. 2005) , which would be expected of an activator of translation. On the other hand, a protein that slows ribosome transit along an mRNA would also be expected to sediment with polysomes, and indeed FMRP has been suggested to do just that (Ceman et al. 2003 ). In addition, metabolic labeling of protein in the hippocampus of Fmr1 knockout mice exceeds that of wild-type mice (Dö len et al. 2007) , again suggesting that FMRP is an inhibitor of translation. However, lessons from developing systems suggest that firm conclusions from even these seemingly straightforward data must be viewed with caution. For example, the completion of the final stages of oocyte meiosis requires a translational regulatory cascade where the very early translational activation of one (or a few) mRNA(s) induces downstream translational activation of some mRNAs but translational repression of other mRNAs (Richter 1996) . It is therefore possible that FMRP activates the translation of some mRNAs at early times of, say, development or following synaptic stimulation, which causes subsequent mRNAspecific translational activation and repression events. That FMRP might repress and activate mRNAs is suggested by the findings of Brown et al. (2001) , who observed that of several mRNAs that were coimmunoprecipitated with FMRP, some sedimented to heavy polysomes, while others shifted to light polysomes in cells lacking FMRP. Thus, FMRP could either be bifunctional-i.e., repressing some mRNAs while activating others-or affect all mRNAs the same way (say, repression), which is followed by a cascade of translational control that is both repressing and activating (see also Bagni and Greenough 2005) .
A recent intriguing model has been proposed for how FMRP regulates translation that has broad implications for translational control in general. Napoli et al. (2008) recently reported that a substantial portion of FMRP sediments in fractions lighter than polysomes; such fractions also contain CYFIP1 (cytoplasmic FMRP interacting protein), a factor that binds FMRP, as well as eIF4E. Surprisingly, CYFIP1 and FMRP are both retained on m 7 GTP (cap)-Sepharose columns, indicating that they directly or indirectly bind the cap. Because both proteins are competed off the column by excess 4E-BP, Napoli et al. (2008) surmised that FMRP and CYFIP bind the cap through an interaction with eIF4E; they further showed that it is CYFIP1 that directly binds eIF4E. CYFIP1 contains a region with some similarity to 4E-BPs, but surprisingly, does not conform to the YXXXXL F (where F is any hydrophobic amino acid, often a leucine) sequence that is common among such proteins (Richter and Sonenberg 2005) . Instead, CYFIP1 has a ''noncanonical'' sequence that is predicted to form two a helices that are nearly identical in structure to those formed by the consensus eIF4E-binding peptide (Marcotrigiano et al. 1999; Napoli et al. 2008 ). The CYFIP1 a helices are stabilized by predicted internal salt bridges and indeed the residues that are thought to form these bridges are necessary for CYFIP1's interaction with eIF4E (Napoli et al. 2008 ). eIF4E-CYFIP1-FMRP complexes can be detected in synaptoneurosome preparations and, upon synaptic stimulation, the CYFIP1-eIF4E interaction is destroyed and FMRP-bound mRNAs undergo enhanced translation.
These results of Napoli et al. (2008) indicate that at least one mode of FMRP-inhibited translation is analogous to that of CPEB. That is, an RNA-binding protein (FMRP or CPEB) is bound to an eIF4E-associated factor (CYFIP1 or Maskin) to preclude the recruitment of eIF4G, and indirectly the 40S ribosomal subunit, to the 59 end of the mRNA (Richter 2007) . One may also infer that molecules with ''Maskin-like'' activities-i.e., mRNAspecific 4E-BPs-may be more widespread than thought previously. For example, Drosophila Cup (Nakamura et al. 2004 ), mammalian 4E-T (Rong et al. 2008) , and mammalian neuroguidin (Jung et al. 2006 ) all contain the YXXXXL F motif noted above and thus resemble Maskin (although Maskin has a threonine in place of the tyrosine); CYFIP1, however, may the first among other soonto-be-discovered molecules with ''noncanonical'' eIF4Ebinding regions that could regulate translation of many sets of mRNAs by associating with different RNAbinding proteins (Fig. 3) .
In addition to the mechanism by which FMRP affects translation, the sequence(s) to which it binds is also complex owing to the fact that the protein contains 2 KH (RNP K homology) domains and a RGG box. FMRP has been reported to bind an unusual intramolecular duplex structure known as a G-quartet through the RGG box ), a small noncoding dsRNA (BC1) via a previously undescribed RNA-binding motif (Zalfa et al. 2003 (Zalfa et al. , 2005 , and a loop-loop pseudoknot ''kissing complex'' via KH domain 2 (Darnell et al. 2005) . However, the only portion of FMRP linked to the FXS is KH domain 2; one individual with an I304N mutation within this region displays several characteristics of the syndrome. Interestingly, the kissing complex, when added in trans, induces a large shift in the sedimentation profile of FMRP such that it is almost exclusively in the mRNP fraction. This result draws a clear connection between the FXS, FMRP KH domain 2, and the kissing complex. Of course, ''the absence of evidence is not evidence of absence,'' and the other domains of FMRP and the RNAs to which they bind could also contribute to the FXS.
The exon junction complex (EJC) and the regulation of synaptic strength
The EJC consists of four core proteins that are probably deposited on most, if not all, exon-exon junctions following intron removal from nuclear pre-mRNA. The four proteins, eIF4AIII, Y14, Mago, and MLN51 travel with the mRNA as it is exported to the cytoplasm where they help dictate the fate of the transcript. Although it is generally thought that the first, or pioneer round of translation causes the dissociation of the EJC from mRNA, prior to this event, this complex can regulate mRNA translation, localization, and destruction in conjunction with other ancillary proteins (Chang et al. 2007; Le Hir and Seraphin 2008; Ma et al. 2008 ). These processes are often interconnected; for example, the EJC can stimulate translation before it dissociates from the mRNA during the first ''pioneer round'' of translation that is important for RNA quality control. Together with Upf1 and other factors, the EJC can influence nonsensemediated mRNA decay (NMD), a surveillance mechanism to ensure that mRNAs with aberrant stop codons are destroyed and do not make improper proteins that could be deleterious to cells.
As noted earlier, translation at synapses is regulated by several factors including mTOR and its effectors and FMRP. Certainly additional translational control mechanisms/factors operate at synapses, and have proposed an intriguing new one. They noted that eIF4AIII, the EJC component, displays a dendritic as well as cell body localization in cultured hippocampal and cortical neurons (in tissue culture cells such as Hela, the preponderance of eIF4AIII is nuclear), and interacts with some dendritic mRNAs such as that encoding arc/arg3.1. Arc/arg3.1 is an immediate early gene whose transcription is induced by a variety of agents and behaviors in the hippocampus (Waung et al. 2008) , all of which probably lead to the activation of N-methyl-D-aspartate receptors (Steward and Worley 2001a) . The arc/arg3.1 39 untranslated region (UTR) is formed from three exons, and thus would be expected to have two EJC complexes; hence, the observed coimmunoprecipitation of this mRNA with eIF4AIII. From this observation, surmised that arc/arg3.1 mRNA could be transported to the synapto-dendritic compartment in a translationally dormant form accompanied by the EJC, and that upon synaptic stimulation, a transient burst of arc/arg3.1 protein synthesis would occur, followed soon thereafter by destruction of the mRNA. Because arc/arg3.1 mRNA EJCs would be located in the 39 UTR, one or a few pioneer rounds of translation presumably would not induce dissociation of the EJC from the mRNA yet the mRNA may still be subject to NMD-like destruction. In this scenario, protein synthesis at synapses would be highly regulated, since after very little translation, the RNA would be destroyed. The evidence that this is the case rests primarily on fact that a knockdown of eIF4AIIIA in cultured neurons leads to increased levels of dendritic arc/arg3.1 protein and RNA levels. The eIF4AIII knockdown also induces increased excitatory synaptic strength, most likely via the addition of glutamate receptors at synapses .
While attractive, the model of would seem to be inconsistent with other observations of arc/ arg3.1 mRNA and protein distribution in vivo. For example, certain behaviors in rats lead to substantial arc/arg3.1 protein levels in hippocampal cell bodies, indicating that the mRNA is not repressed in that location (Ramírez-Amaya et al. 2005) . Similar observations are made when the rat hippocampus is subjected to electrical stimulation that induces LTP (Steward and Figure 3 . Translational control by 4E-BPs. 7mG (cap)-dependent translation depends on ordered interactions among eIF4E, eIF4G, the large multisubunit eIF3, and the 40S ribosomal subunit. The eIF4E-eIF4G interaction can be disrupted by any one of three 4E-BPs, which inhibits the translation of many mRNAs by sequestering eIF4E (Richter and Sonenberg 2005) . The eIF4E-eIF4G interaction can also be disrupted by Maskin, Neuroguidin (Ngd), Bruno, or CYFIP1. Because these proteins are tethered to specific mRNAs via CPEB (and its binding sequence, the CPE), Bruno (and its binding sequence, the BRE), or FMRP (in some cases acting through the small noncoding BC1 RNA), translation is inhibited on only a subset of mRNAs. Steward et al. 2007) . It thus remains unclear whether, or to what extent, arc/arg3.1 mRNA may be transported in dendrites in an inactive form.
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CPEB-regulated molecular circuitry
CPEB is a sequence-specific RNA-binding protein that stimulates translation by inducing cytoplasmic poly(A) elongation (Richter 2007) . In neurons, CPEB is found at post-synaptic sites (as well as the cell body) where in response to synaptic activity, it induces polyadenylation and translation of several mRNAs (Wu et al. 1998; Huang et al. 2002; Shin et al. 2004; Du and Richter 2005) . The importance of this protein for translation in the brain was demonstrated in a CPEB knockout mouse where theta burst-induced LTP was reduced in hippocampal Shaffer CA-1 neurons (Alarcon et al. 2004 ). In addition, CPEB knockout mice have a deficit in extinction, a type of memory where behavioral responses diminish and eventually become extinct when there is no reinforcement of the memory (Berger-Sweeney et al. 2006) . Although extinction requires the formation of new memories, the underlying mechanisms by which it occurs are probably distinct from those of memory acquisition and consolidation (Able and Lattal 2001) .
The key to understanding how CPEB might influence these complex phenotypes surely lies in the identification of target mRNAs. To this end, Zearfoss et al. (2008) have identified grown hormone (GH) as one protein whose level is reduced ;10-fold in the CPEB knockout hippocampus. GH mRNA contains no 39 UTR cytoplasmic polyadenylation elements (CPEs), the binding sites for CPEB, and both GH mRNA and pre-mRNA are reduced in the knockout versus wild-type hippocampus. This result suggested that an mRNA encoding a transcription factor that regulates GH gene expression might be under the direct control of CPEB. Indeed, c-jun is just such a factor; it is reduced in the hippocampus of CPEB knockout mice, its 39 UTR contains CPEs, and it coimmunoprecipitates the promoter of the GH gene in wild type, but not CPEB knockout mice. Surprisingly, GH itself induces LTP in hippocampal slices that, like electrical stimulation, is reduced in the CPEB knockout mouse. Moreover, the LTP induced by GH and theta burst stimulation is reduced if slices are incubated with cordycepin, a drug that inhibits polyadenylation. These and other results suggest that GH acts in both autocrine and paracrine fashion to regulation plasticity through CPEB control of c-jun mRNA translation ( Fig. 4) .
CPEB is also found in invertebrates, and in Aplysia sensory neurons where CPEB RNA has been ablated by an antisense oligonucleotide, long-term facilitation (LTF), a form of plasticity, is not properly maintained (Si et al. 2003a ). However, the isoform of CPEB in Aplysia neurons differs from the CPEB described above in mammals in that it contains a long stretch of glutamine residues. Polyglutamine is sometimes found in proteins that have characteristics of a prion, an infectious agent consisting entirely of protein that is self-reproducing. This observation, plus the fact that CPEB RNA is detected in Aplysia neurons suggested to Si et al. (2003a,b ) that this CPEB isoform might assume a prion-like structure following synaptic stimulation, thereby forming a protease-resistant tag at synapses. If so, then perhaps CPEB itself, as opposed to proteins derived from CPEB-stimulated translation, might comprise the tag that is thought to distinguish stimulated from naive synapses. Si et al. (2003b) indeed showed that Aplysia CPEB had some features of a prion in vitro, such as resistance to protease and fast sedimentation rate in sucrose gradients. The most compelling evidence, however, comes from experiments in yeast, where Alpysia CPEB was shown to assume two forms: one that is aggregated (i.e., prion-like) and one that is not (Si et al. 2003b) . Surprisingly, not only was the (1) CPEB in the synapto-dendritic compartment is activated via N-methyl-D-aspartate receptors (NMDAR) that are stimulated by calcium.
(2) Active CPEB binds the CPE in the c-jun mRNA and stimulates translation. (3) Newly synthesized c-jun protein is transported in retrograde fashion to the nucleus where it stimulates GH transcription. (4) GH is synthesized and secreted; it then interacts with receptors on the same cell (autocrine) or nearby cells (paracrine). The GH receptors signal through phospho-JAK2 and phospho-STAT3, which enters the nucleus to stimulate gene transcription (5), where it modifies plasticity and other signaling events (4). (6) Newly formed NMDA and AMPA receptors maintain LTP. aggregated form of CPEB the only one to bind RNA in vitro, the aggregated form converted the nonaggregated form into an aggregated form. Such epigenetic inheritance is a fundamental hallmark of prion formation. Si et al. (2003b) hypothesized that synaptic stimulation might cause the neuronal Aplysia CPEB isoform to assume a prion-like state, which could stimulate the translation of some RNAs, cause it to alter its substrate specificity, or release some mRNAs from an inhibited state. Si et al. (2003b) further suggest that once in a prion form, CPEB would need no further stimulation (e.g., by kinases) to maintain its activity.
If polyglutamine-containing CPEB forms a prion in invertebrate neurons, then what about the polyglutamine-lacking CPEB in vertebrate neurons? Vertebrates contain three additional CPEB-like genes, all of which are expressed in the brain (Theis et al. 2003) . Two of these other CPEB-like proteins do contain some polyglutamine, although they are not nearly as long as that in the Aplysia CPEB. Moreover, these other CPEB-like proteins do not have a strong affinity for the CPE and do not support cytoplasmic polyadenylation (Huang et al. 2006 ). Thus, the relationship between vertebrate CPEB proteins and prions, if any, remains to be determined. Nonetheless, it is noteworthy that the Drosophila CPEB isoform called Orb2 is found in a head structure (the mushroom bodies) that is important for LTM and contains polyglutamine; when the polyglutamine is deleted, LTM, but not STM is impaired (Keleman et al. 2007) . While these data do not indicate whether prion formation, or even mRNA translation was involved, they do point to the importance of the glutamine stretch for CPEB isoform function in memory formation.
Conclusions
Overwhelming evidence indicates that synapto-dendritic mRNA translation is a necessary component of longlasting synaptic plasticity, but many of the most intriguing questions remain unanswered. Synaptic connections are strengthened by LTP and weakened by LTD, yet both appear to require synapto-dendritic mRNA translation that is stimulated by many of same upstream kinase signaling events. Do LTP and LTD lead different spectra of proteins that are synthesized, and if so, how does this occur? Conversely, if the same proteins are synthesized, how do synapses ''know'' whether to strengthen or weaken? In either case, synaptic tagging, the deposition of a tag or mark at synapse, once it is stimulated to distinguish between those that are naïve from those that are experienced (Frey and Morris 1997) presumably is involved. Kelleher et al. (2004) has suggested that specific tags for LTP and LTD permit the ''capture'' of specific proteins at the synapse, which in turn produce either LTP or LTD. Of course, this begs the question of the nature of the tag, and what distinguishes an LTP tag from an LTD tag. Perhaps relatively rare mRNAs specific for either LTP or LTD are translated at synapses, and that the encoded proteins capture subsequent newly made proteins that produce the biochemical and morphological changes that we recognize as strengthened or weakened synapses. However, protein synthesis inhibitors do not block synaptic tagging in the hippocampus (Frey and Morris 1997) , which argues against newly synthesized proteins being a synaptic tag for either LTP or LTD. Clearly, the identification of the full panoply of translation factor modifications, mRNA-binding proteins, and mRNAs that are translated at synapses is both essential and challenging.
It is also worth noting that some of the same translational control mechanisms that influence LTP and LTM under normal conditions are impaired under certain pathologies of the brain. For example, during ischemia and reperfusion, which often is associated with deficient LTM, there are long-lasting decreases in protein synthesis and increased phosphorylation of eIF2a (DeGracia et al. 2002 ). In addition, increased eIF2a phosphoryation in the brain is associated with epilepsy (Carnevalli et al. 2006) and neuronal culture models of Parkinson's disease (PD) (Holtz and O'Malley 2003) . Moreover, eIF2a phosphorylation increases in the hippocampus of mouse models of Alzheimer's disease (Page et al. 2006; Kim et al. 2007 ), as well as brains of AD patients (Kim et al. 2007 ). Mutations in phosphatase and tensin homolog on chromosome ten (PTEN), a tumor suppressor gene involved in upstream regulation of Akt and mTOR signaling, have been reported in autistic individuals with macrocephaly (Butler et al. 2005) . Mice with a neuron-specific deletion of PTEN exhibit excessive Akt/mTOR signaling and behaviors consistent with autism (Kwon et al. 2006) . As mentioned earlier, mutations in either TSC1 or TSC2, both of which result in up-regulated mTOR signaling, cause TSC that often results in mental retardation and autism (DiMario 2004; Wiznitzer 2004) . Finally, misregulation of mTOR signaling has been implicated in the expression of a cellular marker of neuronal loss in a mouse model of PD (Malagelada et al. 2006 ). Thus, multiple lines of evidence implicate aberrant translational control, especially via altered eIF2a phosphorylation and mTOR signaling, in several neurological disorders.
